Selective COX-2 inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that . The VIGOR (Vioxx Gastrointestinal Outcomes Research) trial, which was the making of Merck;s drug rofecoxib (Vioxx), was at the center of a . Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C...